The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 12, 2017

Filed:

Apr. 03, 2014
Applicant:

Rani Therapeutics, Llc, San Jose, CA (US);

Inventors:

Mir A. Imran, Los Altos Hills, CA (US);

Peter Herrmann, San Jose, CA (US);

Baber Syed, Palo Alto, CA (US);

Timothy H. Williams, Campbell, CA (US);

Chang Jin Ong, Fremont, CA (US);

Greg Method, San Jose, CA (US);

Assignee:

Rani Therapeutics, LLC, San Jose, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61M 5/155 (2006.01); A61M 5/142 (2006.01); A61M 31/00 (2006.01); A61K 38/13 (2006.01); A61K 38/21 (2006.01); A61K 38/26 (2006.01); A61K 38/27 (2006.01); A61K 38/28 (2006.01); A61K 38/29 (2006.01); A61K 38/30 (2006.01); A61K 38/55 (2006.01); A61M 37/00 (2006.01); A61K 9/48 (2006.01);
U.S. Cl.
CPC ...
A61M 5/155 (2013.01); A61K 38/13 (2013.01); A61K 38/21 (2013.01); A61K 38/26 (2013.01); A61K 38/27 (2013.01); A61K 38/28 (2013.01); A61K 38/29 (2013.01); A61K 38/30 (2013.01); A61K 38/55 (2013.01); A61M 5/14244 (2013.01); A61M 31/002 (2013.01); A61K 9/4808 (2013.01); A61M 37/0069 (2013.01); A61M 2205/3331 (2013.01); A61M 2210/1042 (2013.01);
Abstract

Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule, advanced from the capsule into the intestinal wall and degrade within the wall to release the drug to produce a therapeutic effect. The preparation can be coupled to a delivery mechanism having one or more balloons or other expandable devices which are expandable responsive to a condition in the small intestine or other GI lumen to advance the preparation out of the capsule into the intestinal wall. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.


Find Patent Forward Citations

Loading…